drugset / Trial / NCT03414541
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this randomised, double-blind, placebo-controlled, parallel group study is to assess the safety and efficacy of orally administered DS102 capsules versus placebo in the treatment of adult patients with Chronic Obstructive Pulmonary Disease (COPD).
Timeline
- Start
- 2017-09-24
- Primary completion
- 2019-01-11
- Completion
- 2019-01-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DS102 | Unknown | 500 mg | Oral |
| Subject | DS102 | Unknown | 1000 mg | Oral |